More importantly, whether IL‐33 can be used to predict long‐term outcomes in stroke patients warrants further clinical investigation and targeting glial cell IL‐33/ST2 signaling as treatment for stroke needs further intensive study. This evidence concerns the gene IL33 and Stroke.